Short Interest in SeaStar Medical Holding Co. (NASDAQ:ICU) Declines By 8.6%

SeaStar Medical Holding Co. (NASDAQ:ICU) was the target of a significant drop in short interest in the month of April. As of April 15th, there was short interest totalling 3,280,000 shares, a drop of 8.6% from the March 31st total of 3,590,000 shares. Based on an average daily trading volume, of 5,780,000 shares, the days-to-cover ratio is currently 0.6 days. Currently, 6.4% of the company’s stock are sold short.

SeaStar Medical Trading Up 16.8 %

ICU traded up $0.07 during midday trading on Monday, reaching $0.51. The company’s stock had a trading volume of 2,305,896 shares, compared to its average volume of 5,268,230. The stock’s 50-day moving average is $0.76 and its 200-day moving average is $0.68. SeaStar Medical has a 1 year low of $0.16 and a 1 year high of $2.27. The firm has a market capitalization of $38.78 million, a price-to-earnings ratio of -0.42 and a beta of -1.18.

SeaStar Medical (NASDAQ:ICU) last issued its quarterly earnings results on Tuesday, April 16th. The company reported ($0.19) earnings per share for the quarter.

About SeaStar Medical

SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome.